Article

Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-stage Lung Cancer Diagnosis

2020-10-30

Abstract excerpt

<h4>Background: </h4> Lung cancer is a malignant tumor that has the highest morbidity and mortality rate among all cancers. Early diagnosis of lung cancer is a key factor in reducing mortality and improving prognosis. <h4>Methods: </h4>: In this study, we performed CTC next-generation sequencing (NGS) in early-stage lung cancer patients to identify lung cancer-related gene mutations. Meanwhile, a serum liquid chro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7c8f54ed-4caf-5efe-831d-755c7fbf15a3
DOI: 10.21203/rs.3.rs-97860/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-stage Lung Cancer DiagnosisDOI 10.21203/rs.3.rs-97860/v1Read

Multi-omics profiling with untargeted proteomics for blood-based early detection of lung cancerSemantic proximity Read

Targeted metabolomic profiling as a tool for diagnostics of patients with non- small-cell lung cancerSemantic proximity Read

Genomics and the early diagnosis of lung cancerSemantic proximity Read

Exploring AI tools and multi-omics for precision medicine in lung cancer therapy.Semantic proximity Read

Histological and genetic features and therapeutic responses of lung cancers explored via the global analysis of their metabolome profile.Semantic proximity Read

Accurate Early Detection and EGFR Mutation Status Prediction of Lung Cancer Using Plasma cfDNA Coverage Patterns: A Proof-of-Concept Study.Semantic proximity Read

A pilot analysis of circulating cfRNA transcripts for the detection of lung cancerSemantic proximity Read

Data Driven Identification of Plasma Metabolite Clusters and Metabolites of Interest for Potential Detection of Early Stage Non-Small Cell Lung Cancer Cases Versus Cancer-Free ControlsSemantic proximity Read

TTC39C may be a new target for the treatment of lung adenocarcinomaSemantic proximity Read

Integration of clinical phenoms and metabolomics facilitates precision medicine for lung cancer.Semantic proximity Read

A pilot study identifying a potential plasma biomarker for determining EGFR mutations in exons 19 or 21 in lung cancer patients.Semantic proximity Read

Novel targeted agents for the treatment of lung cancer in China.Semantic proximity Read